In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to BAY 12-8039, trovafloxacin, and ciprofloxacin.
Hoppe
J E
JE
Dalhoff
A
A
Pfründer
D
D
D000890:Anti-Infective Agents / Q000494:pharmacology*; D001372:Aza Compounds; D001884:Bordetella / Q000187:drug effects*; D001886:Bordetella pertussis / Q000187:drug effects*; D002939:Ciprofloxacin / Q000494:pharmacology*; D024841:Fluoroquinolones; D008826:Microbial Sensitivity Tests; D000077266:Moxifloxacin; D009287:Naphthyridines / Q000494:pharmacology*; D011804:Quinolines; D015363:Quinolones / Q000494:pharmacology*
D000890:Anti-Infective Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D009287:Naphthyridines; D011804:Quinolines; D015363:Quinolones; D002939:Ciprofloxacin; C080163:trovafloxacin; D000077266:Moxifloxacin